Condition
Gall Stone Disease
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 4 (2)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02327923Phase 4CompletedPrimary
Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy
NCT02568852Not ApplicableCompletedPrimary
Comparison of Coagulation Factors During Laparoscopic Cholecystectomy
NCT02317510Not ApplicableCompletedPrimary
Combined Spinal Epidural Anesthesia and General Anesthesia for Laparoscopic Cholecystectomy
NCT02136095Not ApplicableCompletedPrimary
Promising Initial Experience With Intra-operative Fluorescent Cholangiography
NCT01103570Phase 4Completed
Cholecyst- Versus Cystic Duct Cholangiography During Laparoscopic Cholecystectomy
Showing all 5 trials